Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed) iota | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0147 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0147 | 0.5 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.0147 | 0.0147 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.6715 | 1 |
Schistosoma mansoni | DNA polymerase eta | 0.0023 | 0.0147 | 0.0147 |
Trypanosoma brucei | unspecified product | 0.0023 | 0.0147 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.1679 | 0.2501 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 1 | 1 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.0147 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.6715 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0147 | 0.0219 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0021 | 0.004 | 0.006 |
Echinococcus granulosus | zinc finger protein | 0.0024 | 0.0166 | 0.0166 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0147 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.0147 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0147 | 0.5 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.1239 | 0.1239 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.2798 | 0.2798 |
Echinococcus multilocularis | dna polymerase kappa | 0.0023 | 0.0147 | 0.0147 |
Echinococcus granulosus | dna polymerase eta | 0.0023 | 0.0147 | 0.0147 |
Brugia malayi | PHD-finger family protein | 0.003 | 0.0516 | 0.0561 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0023 | 0.0147 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.0147 | 0.5 |
Leishmania major | DNA polymerase kappa, putative | 0.0023 | 0.0147 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0023 | 0.0147 | 0.5 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.3802 | 0.5565 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0147 | 0.5 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0023 | 0.0147 | 0.0147 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0147 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0147 | 0.5 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.3033 | 0.3033 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0023 | 0.0147 | 0.5 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0023 | 0.0147 | 0.5 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.1239 | 0.1239 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0147 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.0147 | 0.5 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0027 | 0.036 | 0.036 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.2798 | 0.2798 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.0235 | 0.0235 |
Echinococcus multilocularis | geminin | 0.0205 | 1 | 1 |
Echinococcus multilocularis | zinc finger protein | 0.0024 | 0.0166 | 0.0166 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.1399 | 0.2083 |
Echinococcus granulosus | dna polymerase kappa | 0.0023 | 0.0147 | 0.0147 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0023 | 0.0147 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.3522 | 0.5245 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0023 | 0.0147 | 0.0219 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0023 | 0.0147 | 0.5 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0027 | 0.036 | 0.036 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.036 | 0.036 |
Schistosoma mansoni | zinc finger protein | 0.0024 | 0.0166 | 0.0166 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0023 | 0.0147 | 0.0147 |
Leishmania major | DNA polymerase eta, putative | 0.0023 | 0.0147 | 0.5 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0023 | 0.0147 | 0.5 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.1394 | 0.1898 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0147 | 0.5 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0025 | 0.0235 | 0.035 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0023 | 0.0147 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.0147 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.0147 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.6715 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0147 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0147 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0147 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.0147 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.0147 | 0.5 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.0147 | 0.0147 |
Echinococcus multilocularis | dna polymerase eta | 0.0023 | 0.0147 | 0.0147 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.1554 | 0.2314 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | 15.64 uM | PUBCHEM_BIOASSAY: Discovery of Small Molecule Probes for H1N1 Influenza NS1A. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504399] | ChEMBL. | No reference |
Potency (functional) | 2.3323 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 2.8184 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 3.1623 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 6.5131 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 8.9125 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 10.3225 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 20.5878 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.